Dry transglutaminase composition

Details for Australian Patent Application No. 2009240026 (hide)

Owner Novo Nordisk Health Care AG

Inventors Falck, Thomas; Brader, Mark; Kristiansen, Gunhild Klarskov

Agent Shelston IP

Pub. Number AU-A-2009240026

PCT Pub. Number WO2009/130181

Priority 08103642.8 21.04.08 EP

Filing date 20 April 2009

Wipo publication date 29 October 2009

International Classifications

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 38/45 (2006.01) Medicinal preparations containing peptides

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/130181 Priority application(s): WO2009/130181

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009240035-Method and device for securing data transfers

2009240021-Antiviral therapy